2 Juicy Biotech Stocks to Consider Buying Right Now
There are two plays that every biotech investor should know. The first is to buy stock in a company that's very new but that is targeting an unexploited and niche market, typically in the form of a rare and untreated disease. It's a risky move, but when it pays off, it pays off big. In contrast, the second strategy is to invest in an older company that's on the verge of approval with a product targeting a similar market, which is much less risky, but potentially less rewarding.
Today, I'll be discussing one stock for each of these plays. If finding the 10-bagger of tomorrow is up your alley, buckle up.
Image source: Getty Images.
Source Fool.com
